NLA Resources
Glucagon-Like Peptide-1 (GLP-1) agonists
9 Resources
Knowledge Center
The National Lipid Association is your destination for the science of lipid medicine. Now, everything we know is in one place.
Glucagon-Like Peptide-1 (GLP-1) agonists
9 Available Resources
Obesity Therapy: Role for GLP-1 Agonists
The Lipid Panel – The Care of the Diabetic Patient; the Role of GLP1
The Lipid Panel – GLP-1 Receptor Agonists, Weight Loss & Cardiometabolic Health
Non-Lipid Lowering Therapies Impacting Cardiovascular Disease Risk
Atherosclerosis is the leading cause of death and disability globally, with the highest burden continuing to have dominant impact in…
S6E11: Managing Lipids and Metabolic Syndrome in Youth: Tips from the Experts
Join host Peter H. Jones, MD, MNLA for a conversation on the evolving landscape of metabolic health in youth. In…
S6E12: ATTAIN in Practice: Translating Data Into Lipid Decisions
In this episode of Lipid Insights, host Dr. Peter H. Jones is joined by Dr. Harold Bays for a practical, clinician-focused discussion of the ATTAIN…
Case Study: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obesity
Incretins are hormones secreted by intestinal cells in response to the ingestion of glucose and other nutrients. These hormones stimulate…
Novel Advancements in GLP-1 Receptor Agonist Treatment
Introduction Obesity is a complex, chronic medical condition. Although defined by a BMI >30 kg/m2, it is now understood to…
Pharmacotherapy in Obesity: Not Just for Three Months
Overweight and obesity rates continue to climb worldwide, contributing to significant morbidity and mortality, despite several effective pharmacotherapy treatments that…
Join the NLA
Become A Member
When you become a member of the NLA, you become part of a collegial multidisciplinary group of leaders dedicated to improving lipid and cardiometabolic health.
